Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Total Stockholders Equity : $0.0 Mil (As of Mar. 2017)

View and export this data going back to 2009. Start your Free Trial

What is Shandong Luoxin Pharmaceutical Group Stock Co Total Stockholders Equity?

Shandong Luoxin Pharmaceutical Group Stock Co's Total Stockholders Equity for the quarter that ended in Mar. 2017 was $0.0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Shandong Luoxin Pharmaceutical Group Stock Co's Book Value per Share for the quarter that ended in Mar. 2017 was $N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Shandong Luoxin Pharmaceutical Group Stock Co's Debt-to-Equity for the quarter that ended in Mar. 2017 was .

Shandong Luoxin Pharmaceutical Group Stock Co Total Stockholders Equity Historical Data

The historical data trend for Shandong Luoxin Pharmaceutical Group Stock Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Luoxin Pharmaceutical Group Stock Co Total Stockholders Equity Chart

Shandong Luoxin Pharmaceutical Group Stock Co Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Total Stockholders Equity

Get a 7-Day Free Trial

294.74

342.91

378.67

411.40

407.40

Shandong Luoxin Pharmaceutical Group Stock Co Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Total Stockholders Equity	Get a 7-Day Free Trial															-	400.51	-	407.40	-

Shandong Luoxin Pharmaceutical Group Stock Co (OTCPK:SLUXY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Shandong Luoxin Pharmaceutical Group Stock Co's Book Value per Share for the quarter that ended in Mar. 2017 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0	-	0)	/	60.96
	=	N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Shandong Luoxin Pharmaceutical Group Stock Co's Debt-to-Equity for the quarter that ended in Mar. 2017 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=

Shandong Luoxin Pharmaceutical Group Stock Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shandong Luoxin Pharmaceutical Group Stock Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Luoxin Pharmaceutical Group Stock Co Ltd (OTCPK:SLUXY) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

Website

http://www.luoxin.cn

Shandong Luoxin Pharmaceutical Group Stock Co Ltd along with its subsidiaries is engaged in the manufacturing and selling of pharmaceutical products. It is involved in the research and development of LXI-15028, a potassium-competitive acid blocker, which is in phase III development for the treatment of reflux esophagitis and other acid-related gastrointestinal diseases; and LXI-15029, an ATP mTOR kinase inhibitor that acts as potent and selective dual inhibitors of mTORC1 and mTORC2 that controls the process of tumor formation and growth. The company mainly operates in the People's Republic of China.

Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Headlines

No Headlines